AU2002239753A1 - Proteases - Google Patents

Proteases

Info

Publication number
AU2002239753A1
AU2002239753A1 AU2002239753A AU3975302A AU2002239753A1 AU 2002239753 A1 AU2002239753 A1 AU 2002239753A1 AU 2002239753 A AU2002239753 A AU 2002239753A AU 3975302 A AU3975302 A AU 3975302A AU 2002239753 A1 AU2002239753 A1 AU 2002239753A1
Authority
AU
Australia
Prior art keywords
proteases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002239753A
Inventor
Chandra Arvizu
Janice Au-Young
Yalda Azimzai
Mariah R. Baughn
Mark L. Borowsky
Neil Burford
Narinder K. Chawla
Angelo M Delegeane
Vicki S. Eliliott
Ameena R. Gandhi
Jennifer A. Griffin
April J.A. Hafalia
Craig H. Ison
Deborah A. Kallick
Liam Kearney
Preeti G. Lal
Ernestine A. Lee
Sally Lee
Terence P. Lo
Dyung Aina M. Lu
Yan Lu
Danniel B. Nguyen
Jayalaxmi Ramkumar
Anita Swarnakar
Y. Tom Tang
Kavitha Thangavelu
Catherine M. Tribouley
Bridget A. Warren
Yuming Xu
Monique G. Yao
Henry Yue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2002239753A1 publication Critical patent/AU2002239753A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
AU2002239753A 2000-10-18 2001-10-18 Proteases Abandoned AU2002239753A1 (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US24157300P 2000-10-18 2000-10-18
US60/241,573 2000-10-18
US24364300P 2000-10-25 2000-10-25
US60/243,643 2000-10-25
US24525600P 2000-11-02 2000-11-02
US60/245,256 2000-11-02
US24839500P 2000-11-13 2000-11-13
US60/248,395 2000-11-13
US24982600P 2000-11-16 2000-11-16
US60/249,826 2000-11-16
US25230300P 2000-11-20 2000-11-20
US60/252,303 2000-11-20
US25098100P 2000-12-01 2000-12-01
US60/250,981 2000-12-01
PCT/US2001/051034 WO2002038744A2 (en) 2000-10-18 2001-10-18 Proteases

Publications (1)

Publication Number Publication Date
AU2002239753A1 true AU2002239753A1 (en) 2002-05-21

Family

ID=27569436

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002239753A Abandoned AU2002239753A1 (en) 2000-10-18 2001-10-18 Proteases

Country Status (5)

Country Link
EP (1) EP1387886A2 (en)
JP (1) JP2004535153A (en)
AU (1) AU2002239753A1 (en)
CA (1) CA2425829A1 (en)
WO (1) WO2002038744A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6683165B1 (en) 1999-04-13 2004-01-27 Genome Therapeutics Corporation Human gene relating to respiratory diseases and obesity
WO2001078894A2 (en) * 2000-04-13 2001-10-25 Schering Corporation Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
WO2002066643A2 (en) * 2000-11-13 2002-08-29 Curagen Corporation Proteins, polynucleotides encoding them and methods of using the same
DE60126659T2 (en) * 2000-12-25 2007-10-31 Astellas Pharma Inc. NEW PROTEASE
WO2002059317A2 (en) * 2001-01-24 2002-08-01 Zymogenetics, Inc. Cub domain protein zcub3 and materials and methods for making it
EP1567642A4 (en) 2001-04-03 2006-02-08 Bristol Myers Squibb Co Polynucleotide encoding a novel cysteine protease of the calpain superfamily, can-12, and variants thereof
WO2003104394A2 (en) * 2002-05-21 2003-12-18 Dendreon San Diego Llc Nucleic acid molecules encoding a transmembrane serine protease 12, the encoded polypeptides and methods based thereon
CA2494793A1 (en) * 2002-07-31 2004-02-05 Yamanouchi Pharmaceutical Co., Ltd. Novel serine protease
BR122021014783B1 (en) * 2008-12-19 2023-03-14 Baxalta GmbH TFPI-BINDING PEPTIDE, USE OF THE PEPTIDE, PHARMACEUTICAL COMPOSITION AND METHOD FOR PURIFICATION OF TFPI
BR112021026192A2 (en) 2019-06-24 2022-06-07 Urteste S A Diagnostic marker for pancreatic cancer
EP3845664A1 (en) * 2020-01-02 2021-07-07 Urteste Sp. z o.o. Novel diagnostic marker for prostate cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2126455A1 (en) * 1993-02-05 1994-08-06 Andrew R. Milner Liver fluke vaccine and polypeptides useful for same
US6544767B1 (en) * 1994-10-27 2003-04-08 Axys Pharmaceuticals, Inc. Cathespin O2 protease

Also Published As

Publication number Publication date
EP1387886A2 (en) 2004-02-11
WO2002038744A2 (en) 2002-05-16
WO2002038744A3 (en) 2003-11-20
CA2425829A1 (en) 2002-05-16
JP2004535153A (en) 2004-11-25

Similar Documents

Publication Publication Date Title
AU2001269836A1 (en) Proteases
AU2001271427A1 (en) Novel proteases
AU2001262847A1 (en) Language-understanding
AU2001292739A1 (en) 1-oxorapamycins
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2002211620A1 (en) Autoanastomosis
AU2001258349A1 (en) Bisacylguanidine
AU2001296577A1 (en) Chlorophyllases
AU2001279754A1 (en) Indoloquinazolinones
AU2002224553A1 (en) Human proteases
AU2002211128A1 (en) Step-bike
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU2001290931A1 (en) Ski-snowboard
AU2001293852A1 (en) Sulfonylguanidine
AU2001258924A1 (en) Microsatellite-aflp
AU2002239753A1 (en) Proteases
AU2002226346A1 (en) 2-aryl-5-trifluoromethylpyridines
AU2001247483A1 (en) Proteases
AU2001281921A1 (en) Bdellosomes
AU2001292594A1 (en) Proteases
AU2001246864A1 (en) Hypotensors
AU2001291876A1 (en) Triazolo-epothilones